Compounds > calcium dobesilate
Page last updated: 2024-08-23

calcium dobesilate and Agranulocytosis

calcium dobesilate has been researched along with Agranulocytosis in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (37.50)18.2507
2000's4 (50.00)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
García, AG; Horga de la Parte, JF; Zapater Hernández, P1
García, A; Horga, JF; Zapater, P1
Duggal, L; Kumar, S; Thukral, R1
Blasco Mascaró, I; Cladera Serra, A; Oliva Berini, E; Ramos Díaz, F1
García Benayas, E; García Díaz, B; Pérez, G1
Ballarín, E; Ibáñez, L; Laporte, JR; Vidal, X1
Becker, EW; Berg, PA; Kulessa, W1

Other Studies

8 other study(ies) available for calcium dobesilate and Agranulocytosis

ArticleYear
Calcium dobesilate: neutropenia.
    Prescrire international, 2010, Volume: 19, Issue:109

    Topics: Aged; Agranulocytosis; Calcium Dobesilate; Humans; Male; Neutropenia

2010
[Risk of drug-induced agranulocytosis: an approximation to risk analysis arising from spontaneous notification of agranulocytosis cases among patients treated with calcium dobesilate].
    Anales de medicina interna (Madrid, Spain : 1984), 2002, Volume: 19, Issue:6

    Topics: Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Agranulocytosis; Algorithms; Calcium Dobesilate; Case-Control Studies; Europe; Female; Follow-Up Studies; Humans; Israel; Male; Middle Aged; Multicenter Studies as Topic; Poisson Distribution; Prospective Studies; Risk Assessment; Spain

2002
Risk of drug-induced agranulocytosis: the case of calcium dobesilate.
    European journal of clinical pharmacology, 2003, Volume: 58, Issue:11

    Topics: Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Agranulocytosis; Calcium Dobesilate; Case-Control Studies; Drug Administration Schedule; Female; Hemostatics; Humans; Male; Poisson Distribution; Product Surveillance, Postmarketing; Risk Assessment; Spain

2003
Calcium dobesilate-induced agranulocytosis.
    The Journal of the Association of Physicians of India, 2005, Volume: 53

    Topics: Aged; Agranulocytosis; Anemia, Aplastic; Calcium Dobesilate; Female; Hemostatics; Humans

2005
[Agranulocytosis induced by calcium dobesilate].
    Medicina clinica, 1995, Oct-28, Volume: 105, Issue:14

    Topics: Aged; Agranulocytosis; Calcium Dobesilate; Female; Hemorrhoids; Hemostatics; Humans; Time Factors

1995
Calcium dobesilate-induced agranulocytosis.
    Pharmacy world & science : PWS, 1997, Volume: 19, Issue:5

    Topics: Agranulocytosis; Calcium Dobesilate; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Hemostatics; Humans; Male; Middle Aged

1997
Agranulocytosis associated with calcium dobesilate clinical course and risk estimation with the case-control and the case-population approaches.
    European journal of clinical pharmacology, 2000, Volume: 56, Issue:9-10

    Topics: Aged; Agranulocytosis; Anemia, Aplastic; Calcium Dobesilate; Case-Control Studies; Female; Follow-Up Studies; Hemostatics; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Population; Risk Assessment

2000
[Recurrent agranulocytosis after taking calcium dobesilate].
    Deutsche medizinische Wochenschrift (1946), 1992, Mar-06, Volume: 117, Issue:10

    Topics: Agranulocytosis; Calcium Dobesilate; Cefotaxime; Drug Hypersensitivity; Female; Humans; Lymphocyte Activation; Middle Aged; Ofloxacin; Pyoderma; Recurrence

1992